Full Text
The Full Text of this article is available as a PDF (200.6 KB).
. 2004 Apr;75(4):634–636. doi: 10.1136/jnnp.2003.010769
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease
J Scholz
1, I Klingemann
1, A Moser
1
J Scholz
1Neurochemistry Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany. scholz.joachim@mgh.harvard.edu
Find articles by J Scholz
I Klingemann
1Neurochemistry Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany. scholz.joachim@mgh.harvard.edu
Find articles by I Klingemann
A Moser
1Neurochemistry Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany. scholz.joachim@mgh.harvard.edu
Find articles by A Moser
1Neurochemistry Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany. scholz.joachim@mgh.harvard.edu
PMCID: PMC1739023 PMID: 15026514